Groupe PARIMA Joins PBOA

Quebec, Canada-based contract development and manufacturing organization has joined the Pharma & Biopharma Outsourcing Association.

Groupe PARIMA, a Quebec, Canada-based contract development and manufacturing organization (CDMO) specializing in non-sterile liquid, suspension, semi-solid, and spray drug products, has joined the Pharma & Biopharma Outsourcing Association (PBOA), a trade association for contract manufacturing and CDMOs, as a general member.

“With the rapid evolution of the pharmaceutical industry, the role of CDMOs has increased in prominence, working in ever-closer partnerships with our clients. Groupe PARIMA is enthusiastically joining PBOA to support the important efforts of the association and to contribute to the development of solutions to meet our collective challenges. We are convinced that this association of industry leaders will continue to work effectively with all stakeholders to find better ways to serve patients by helping to insure a reliable supply of high-quality and affordable medications,” said Louis-David Cantin, president of Groupe PARIMA, in a statement.

 “I’ve known the team at Groupe PARIMA for a long time and I’m delighted to bring them into the PBOA. Our association’s mission is not only to represent our industry in the regulatory and legislative areas, but also to give CDMOs the opportunity to learn best practices from each other and to grow as a sector. Groupe PARIMA will be a valuable addition to the PBOA, including our Quality Technical Group,” said Gil Roth, President of the PBOA, in an Aug. 11, 2016 announcement.